δ-Catenin overexpression promotes angiogenic potential of CWR22Rv-1 prostate cancer cells via HIF-1α and VEGF

FEBS Letters

Volumn 587, Issue 2, 2013, Pages 193-199

  He, Yongfeng ^a   Kim, Hangun ^b   Ryu, Taeyong ^a   Kang, Youra ^c   Kim, Jeong Ae ^c   Kim, Bo Hyun ^a   Lee, Jae Hyuk ^d   Kang, Keonwook ^e   Lu, Qun ^f   Kim, Kwonseop ^a,d  

^a Chonnam National University   (South Korea)

^b Sunchon National University   (South Korea)

^c Yeungnam University   (South Korea)

^d Chonnam National University Medical School   (South Korea)

^e Seoul National University   (South Korea)

^f EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Catenin; Catenin NPRAP; Angiogenesis; HIF 1 ; VEGF

Indexed keywords

BETA CATENIN; CATENIN; DELTA CATENIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL NUCLEUS; CONTROLLED STUDY; EMBRYO; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

ANIMALS; CATENINS; CELL LINE, TUMOR; CELL NUCLEUS; CHICK EMBRYO; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84872116039     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.11.024     Document Type: Article

References (28)

1. W. Risau Mechanisms of angiogenesis Nature 386 1997 671 674
2. A.I. Holleb, and J. Folkman Tumor angiogenesis CA Cancer J. Clin. 22 1972 226 229
3. R. Oklu, T.G. Walker, S. Wicky, and R. Hesketh Angiogenesis and current antiangiogenic strategies for the treatment of cancer J. Vasc. Interv. Radiol. 21 2010 1791 1805 quiz 1806
4. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
5. J. Zhou, U. Liyanage, M. Medina, C. Ho, A.D. Simmons, M. Lovett, and K.S. Kosik Presenilin 1 interaction in the brain with a novel member of the Armadillo family NeuroReport 8 1997 2085 2090
6. Q. Lu, L.J. Dobbs, C.W. Gregory, G.W. Lanford, M.P. Revelo, S. Shappell, and Y.H. Chen Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer Human Pathol. 36 2005 1037 1048
7. Q. Lu, J. Zhang, R. Allison, H. Gay, W.X. Yang, N.A. Bhowmick, G. Frelix, S. Shappell, and Y.H. Chen Identification of extracellular delta-catenin accumulation for prostate cancer detection Prostate 69 2009 411 418
8. M.J. Burger, M.A. Tebay, P.A. Keith, H.M. Samaratunga, J. Clements, M.F. Lavin, and R.A. Gardiner Expression analysis of delta-catenin and prostate-specific membrane antigen: their potential as diagnostic markers for prostate cancer Int. J. Cancer 100 2002 228 237
9. Y. Fang, Z. Li, X. Wang, and S. Zhang Expression and biological role of delta-catenin in human ovarian cancer J. Cancer Res. Clin. Oncol. 138 2012 1769 1776
10. X.Y. Li, S.L. Liu, N. Cha, Y.J. Zhao, S.C. Wang, W.N. Li, E.H. Wang, and G.P. Wu Transcription expression and clinical significance of dishevelled-3 mRNA and delta-catenin mRNA in pleural effusions from patients with lung cancer Clin. Dev. Immunol. 2012 2012 904946
11. J.Y. Zhang, D. Zhang, and E.H. Wang Overexpression of small GTPases directly correlates with expression of delta-catenin and their coexpression predicts a poor clinical outcome in nonsmall cell lung cancer Mol. Carcinog. 2011 101002/mc. 21854
12. S.D. Dai, Y. Wang, J.Y. Zhang, D. Zhang, P.X. Zhang, G.Y. Jiang, Y. Han, S. Zhang, Q.Z. Cui, and E.H. Wang Upregulation of delta-catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non-small-cell lung cancer Cancer Sci. 102 2011 95 103
13. J.Y. Zhang, Y. Wang, D. Zhang, Z.Q. Yang, X.J. Dong, G.Y. Jiang, P.X. Zhang, S.D. Dai, Q.Z. Dong, Y. Han, S. Zhang, Q.Z. Cui, and E.H. Wang Delta-catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm J. Pathol. 222 2010 76 88
14. L.M. DeBusk, K. Boelte, Y. Min, and P.C. Lin Heterozygous deficiency of delta-catenin impairs pathological angiogenesis J. Exp. Med. 207 2010 77 84
15. J.A. Kim, K.B. Cho, M.R. Kim, B.C. Park, S.K. Kim, M.Y. Lee, and K.W. Kang Decreased production of vascular endothelial growth factor in adriamycin-resistant breast cancer cells Cancer Lett. 268 2008 225 232
16. B.C. Park, S.Y. Park, J.S. Lee, S.A. Mousa, J.T. Kim, M.K. Kwak, K.W. Kang, E.S. Lee, H.G. Choi, C.S. Yong, and J.A. Kim The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling Vascul. Pharmacol. 50 2009 123 131
17. Y. Zeng, A. Abdallah, J.P. Lu, T. Wang, Y.H. Chen, D.M. Terrian, K. Kim, and Q. Lu Delta-catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles Mol. Cancer 8 2009 19
18. H. Kim, Y. He, I. Yang, Y. Zeng, Y. Kim, Y.W. Seo, M.J. Murnane, C. Jung, J.H. Lee, J.J. Min, D.D. Kwon, K.K. Kim, Q. Lu, and K. Kim Delta-catenin promotes E-cadherin processing and activates beta-catenin-mediated signaling: implications on human prostate cancer progression Biochim. Biophys. Acta 1822 2012 509 521
19. A. Kaidi, A.C. Williams, and C. Paraskeva Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia Nat. Cell Biol. 9 2007 210 217
20. F.H. Dilek, N. Topak, C. Tokyol, G. Akbulut, and O.N. Dilek Beta-catenin and its relation to VEGF and cyclin D1 expression in pT3 rectosigmoid cancers Turk. J. Gastroenterol. 21 2010 365 371
21. H. Matono, S. Tamiya, R. Yokoyama, T. Saito, Y. Iwamoto, M. Tsuneyoshi, and Y. Oda Abnormalities of the Wnt/beta-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between beta-catenin widespread nuclear expression and VEGF overexpression Histopathology 59 2011 368 375
22. P. Watcharasit, S. Suntararuks, D. Visitnonthachai, A. Thiantanawat, and J. Satayavivad Beta-catenin involvement in arsenite-induced VEGF expression in neuroblastoma SH-SY5Y cells Environ. Toxicol. 2012 10.1002/tox.21794
23. V. Easwaran, S.H. Lee, L. Inge, L. Guo, C. Goldbeck, E. Garrett, M. Wiesmann, P.D. Garcia, J.H. Fuller, V. Chan, F. Randazzo, R. Gundel, R.S. Warren, J. Escobedo, S.L. Aukerman, R.N. Taylor, and W.J. Fantl Beta-catenin regulates vascular endothelial growth factor expression in colon cancer Cancer Res. 63 2003 3145 3153
24. M. Oh, H. Kim, I. Yang, J.H. Park, W.T. Cong, M.C. Baek, S. Bareiss, H. Ki, Q. Lu, J. No, I. Kwon, J.K. Choi, and K. Kim GSK-3 phosphorylates delta-catenin and negatively regulates its stability via ubiquitination/ proteosome-mediated proteolysis J. Biol. Chem. 284 2009 28579 28589
25. D. Flugel, A. Gorlach, C. Michiels, and T. Kietzmann Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner Mol. Cell. Biol. 27 2007 3253 3265
26. C. Koutras, C.B. Lessard, and G. Levesque A nuclear function for the presenilin 1 neuronal partner NPRAP/delta-catenin J. Alzheimer's Dis. 27 2011 307 316
27. D. Gu, N.K. Tonthat, M. Lee, H. Ji, K.P. Bhat, F. Hollingsworth, K.D. Aldape, M.A. Schumacher, T.P. Zwaka, and P.D. McCrea Caspase-3 cleavage links delta-catenin to the novel nuclear protein ZIFCAT J. Biol. Chem. 286 2011 23178 23188
28. M. Rodova, K.F. Kelly, M. VanSaun, J.M. Daniel, and M.J. Werle Regulation of the rapsyn promoter by kaiso and delta-catenin Mol. Cell. Biol. 24 2004 7188 7196